Transaction · 0001104659-26-011524

Sherman Darren

Sherman Darren, SR, reported a transaction classified as grant at Orchestra BioMed Holdings, Inc. involving 34974.000000 shares for an estimated $0.00. Reported holdings after the transaction were 34974.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ASR
OBIOOrchestra BioMed Holdings, Inc.
Filing timeFeb 06
Trade dateJan 28, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.91
Pre-filing
1mo ago +7.7%1w ago +4.6%1d ago +6.4%
Returns since
7d -2.0%30d +10.5%90d +0.5%180d +7.9%1y +32.5%

OBIO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
OBIO since 2026-02-06Filed 209 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001104659-26-011524
Stock Option
Transaction date
Jan 28, 2026
Filed Feb 06, 2026, 09:15 PM · 9d delay
Shares
34.9k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
34.9k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 9 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Derivative Transaction Direct Ownership Large Holdings Increase
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This date represents the date of vesting of a performance stock option granted on April 23, 2025.

  2. F2

    The stock option vests over a four-year period as follows: 25% on the April 23, 2026 (the "Vesting Commencement Date") with the remaining 75% vesting in equal installments every three months thereafte…

Original filing · 0001104659-26-011524
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

OBIO